Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500 Futures
(0.17%) 5 336.25 points
Dow Jones Futures
(0.06%) 40 161 points
Nasdaq Futures
(0.28%) 18 687 points
Oil
(-0.45%) $79.70
Gas
(1.49%) $2.67
Gold
(0.63%) $2 432.70
Silver
(1.49%) $31.73
Platinum
(-0.83%) $1 081.00
USD/EUR
(0.05%) $0.920
USD/NOK
(0.05%) $10.68
USD/GBP
(0.06%) $0.788
USD/RUB
(-0.38%) $90.62

Realtime updates for Amicus Therapeutics, Inc. [0HF9.L]

Exchange: London Stock Exchange Sector: Healthcare Industry: Medical - Pharmaceuticals
Last Updated16 May 2024 @ 11:21
25% discount on Stockinvest.us - Use code: Podcast

-1.79% $ 9.42

Live Chart Being Loaded With Signals

Commentary (16 May 2024 @ 11:21):

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data...

Stats
Today's Volume 9 847.00
Average Volume 814.00
Market Cap 2.79B
EPS $0 ( 2024-05-09 )
Next earnings date ( $0 ) 2024-08-06
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -9.68
ATR14 $0 (0.00%)

Amicus Therapeutics, Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Amicus Therapeutics, Inc. Financials

Annual 2023
Revenue: $399.36M
Gross Profit: $354.16M (88.68 %)
EPS: $-0.510
FY 2023
Revenue: $399.36M
Gross Profit: $354.16M (88.68 %)
EPS: $-0.510
FY 2022
Revenue: $329.23M
Gross Profit: $285.29M (86.65 %)
EPS: $-0.820

Financial Reports:

No articles found.

Amicus Therapeutics, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases; CLN3, which is in Phase 1/2 clinical study to evaluate the safety and efficacy of a single intrathecal administration of an AAV serotype AT-GTX-502 gene therapy in patients with CLN3; and CDKL5, a gene on the X-chromosome encoding the CDKL5 protein that regulates the expression of essential proteins for normal brain development. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators